Network-level effects of kinase inhibitors modulate TNF-α-induced apoptosis in the intestinal epithelium

Jessica J Gierut1, Levi B Wood1,2, Ken S Lau3,4

  • 1Cancer Research Institute, Beth Israel Deaconess Cancer Center and Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.

Science Signaling
|December 17, 2015
PubMed

Insights

Pathway inhibitors targeting mitogen-activated protein kinase (MAPK) signaling have distinct effects on tumor necrosis factor-α (TNF-α)-induced apoptosis. Network context and specific inhibitors, like CH5126766, critically influence cellular responses.

Area of Science:

  • Cellular signaling networks
  • Molecular biology
  • Immunology

Background:

  • Cellular responses to signals like tumor necrosis factor-α (TNF-α) are influenced by the overall signaling network state.
  • Inhibition of specific pathways, such as mitogen-activated protein kinase (MAPK), can alter these responses, as seen with TNF-α-induced apoptosis in the mouse intestine.

Purpose of the Study:

  • To investigate if MAPK signaling directly impacts TNF-α-induced apoptosis or if network-level effects mediate the cellular response.
  • To determine the distinct effects of inhibiting different components of the MAPK pathway (Raf, MEK, ERK) on TNF-α-induced apoptosis.

Main Methods:

  • Utilized inhibitors targeting Raf, MEK, and extracellular signal-regulated kinase (ERK) in mouse intestinal epithelium models.
  • Employed computational modeling and experimental perturbations to identify key signaling nodes.
  • Analyzed the timing and magnitude of TNF-α-induced apoptosis under various inhibition conditions.

Main Results:

  • Inhibitors of Raf, MEK, and ERK demonstrated varied effects on the timing and magnitude of TNF-α-induced apoptosis.
  • Different MEK inhibitors produced distinct outcomes: CH5126766 potentiated apoptosis, while others reduced it.
  • The kinase Akt was identified as a crucial node mediating apoptosis enhancement when CH5126766 was present alongside TNF-α signaling.

Conclusions:

  • The study underscores the critical role of integrated signaling networks in dictating cellular behavior.
  • It highlights the importance of considering network-level consequences when using pathway inhibitors.
  • Demonstrates that inhibitors targeting the same pathway can elicit significantly different cellular responses.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
740
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K